MyoCon! September 24–27, 2026.Each year, The Myositis Association (TMA) recognizes individuals whose stories help shine a light on myositis and inspire others living with these rare diseases. As part of our 2026 Heroes…
Continue Reading
Dr. Chris Weihl Receives TMA’s 2026 Heroes in Research Award
Scientific progress begins with curiosity, dedication, and a commitment to improving lives. This year, The Myositis Association (TMA) is proud to recognize Conrad “Chris” Weihl, MD, PhD, as the recipient…
Continue Reading
Hospital for Special Surgery Receives TMA’s 2026 Heroes in Healthcare Award
Every year, The Myositis Association (TMA) honors individuals and organizations whose dedication, innovation, and compassion make a lasting difference in the lives of those affected by myositis. As part of…
Continue Reading
New Hope on the Horizon
Promising Trial News from argenx and Abcuro The myositis community recently received encouraging news from two companies developing treatments for different forms of myositis. While much work remains before these…
Continue Reading
From Volcanic Soil to a Possible Treatment for IBM
By Nataliya Slater Our team in Australia is leading a clinical trial investigating sirolimus (rapamycin) as a potential treatment for inclusion body myositis (IBM). But do you know the remarkable…
Continue Reading